Paper35774792
microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate.
Dominguez-Mozo MI and 10 others. Front Immunol, 2022. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate. Papers, record 35774792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35774792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Diseases | Major topic |
| MicroRNAs | Major topic |
| Multiple Sclerosis | Major topic |
| Neurodegenerative Diseases | Major topic |
| Atrophy | |
| Biomarkers | |
| Brain | |
| Cross-Sectional Studies | |
| Glatiramer Acetate | |
| Humans |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29043654 | Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability. | J Mol Neurosci | 2017 | https://conductscience.org/library/papers/29043654 | PubMed |
| 2 | 24901013 | Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. | J Immunol Res | 2014 | https://conductscience.org/library/papers/24901013 | PubMed |
| 3 | 31638082 | MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression. | Neural Regen Res | 2020 | https://conductscience.org/library/papers/31638082 | PubMed |
| 4 | 32199199 | miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta. | J Neuroimmunol | 2020 | https://conductscience.org/library/papers/32199199 | PubMed |
| 5 | 23494648 | Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. | Ann Neurol | 2013 | https://conductscience.org/library/papers/23494648 | PubMed |
| 6 | 12607150 | Minimal neuropsychological assessment of MS patients: a consensus approach. | Clin Neuropsychol | 2002 | https://conductscience.org/library/papers/12607150 | PubMed |
| 7 | 28872459 | miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28872459 | PubMed |
| 8 | 22190573 | Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). | Mult Scler | 2012 | https://conductscience.org/library/papers/22190573 | PubMed |
| 9 | 19617918 | Differential micro RNA expression in PBMC from multiple sclerosis patients. | PLoS One | 2009 | https://conductscience.org/library/papers/19617918 | PubMed |
| 10 | 31606972 | Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis. | Cell J | 2020 | https://conductscience.org/library/papers/31606972 | PubMed |
| 11 | 24852919 | Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients. | Mult Scler | 2014 | https://conductscience.org/library/papers/24852919 | PubMed |
| 12 | 34179535 | Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis. | Heliyon | 2021 | https://conductscience.org/library/papers/34179535 | PubMed |
| 13 | 26954942 | MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response. | Shock | 2016 | https://conductscience.org/library/papers/26954942 | PubMed |
| 14 | 25860297 | Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα. | Arthritis Res Ther | 2015 | https://conductscience.org/library/papers/25860297 | PubMed |
| 15 | 20850013 | Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. | Cell | 2010 | https://conductscience.org/library/papers/20850013 | PubMed |
| 16 | 30126230 | The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30126230 | PubMed |
| 17 | 25947625 | MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression. | J Transl Med | 2015 | https://conductscience.org/library/papers/25947625 | PubMed |
| 18 | 23643683 | Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases. | Neurologia | 2013 | https://conductscience.org/library/papers/23643683 | PubMed |
| 19 | 27725128 | Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis. | J Neuroimmunol | 2016 | https://conductscience.org/library/papers/27725128 | PubMed |
| 20 | 32432792 | Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients. | Acta Neurol Scand | 2020 | https://conductscience.org/library/papers/32432792 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42511484 | MicroRNA Expression Profiles as Biomarkers of Response to Disease-Modifying Therapies in Multiple Sclerosis: A Systematic Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511484 | PubMed |
| 42032299 | Blood-derived microRNA signatures associated with hippocampal structure and atrophy rate: findings from the Rhineland Study. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42032299 | PubMed |
| 40943658 | From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943658 | PubMed |
| 40677715 | Short-term exposure to particulate matter triggers a selective alteration of plasma extracellular vesicle-packaged miRNAs in a mouse model of multiple sclerosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40677715 | PubMed |
| 39337499 | Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337499 | PubMed |
| 38255959 | Circulating microRNA miR-425-5p Associated with Brain White Matter Lesions and Inflammatory Processes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38255959 | PubMed |
| 37893133 | MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate. | Biomedicines | 2023 | https://conductscience.org/library/papers/37893133 | PubMed |
| 37881368 | Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis. | Front Mol Neurosci | 2023 | https://conductscience.org/library/papers/37881368 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 | NCBI Gene |
| MBP | 4155 | PubTator's text mining | https://conductscience.org/library/genes/4155 | NCBI Gene |
| MIR1263 | 100302148 | PubTator's text mining | https://conductscience.org/library/genes/100302148 | NCBI Gene |
| MIR155 | 406947 | PubTator's text mining | https://conductscience.org/library/genes/406947 | NCBI Gene |
| MIR191 | 406966 | PubTator's text mining | https://conductscience.org/library/genes/406966 | NCBI Gene |
| MIR30C1 | 407031 | PubTator's text mining | https://conductscience.org/library/genes/407031 | NCBI Gene |
| MIR326 | 442900 | PubTator's text mining | https://conductscience.org/library/genes/442900 | NCBI Gene |
| MIR95 | 407052 | PubTator's text mining | https://conductscience.org/library/genes/407052 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35774792
GET https://conductscience.org/api/papers/v1/35774792/references?page=2